Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      From Enrollment to Informed Consent, Nurses Are Vital in the Clinical Trial Process

      April 17, 2019
      By Brielle Benyon
      Article

      Oncology nurses are valuable players in enrolling patients in clinical trials, and then guiding them through the process — especially when it comes to complicated informed consent documents – explained Katie Goodman, RN, BSN, CCRP, the director of clinical research at Florida Cancer Specialists.

      “The oncology nurse plays a critical role in the management of patients on a clinical trial,” Goodman said in a recent interview with Oncology Nursing News.

      Oncology Nursing News: What role do oncology nurses play in clinical trial recruitment and support?

      Goodman: We feel that physicians will largely identify patients who are eligible for clinical trials, but the nurse will oftentimes facilitate the work that has to happen to get a patient on the trial. We follow the protocol to get baseline testing performed according to the protocol schedule, and then we really work to get the patient on the study.

      We educate the patients on the things they need to know. We will often go through the consent form page by page, which can sometimes be 10 or 15 pages long in oncology. The oncology nurse will spend a lot of time with the patients, making sure they truly understand that consent form and what's involved in the clinical trial.

      Once the patient enrolls, nurses will then also meet with them at nearly every visit to do things like review all of their current medications that they might be on, any side effects that they might be experiencing, and again helping the patient to manage any side effects that they have.

      What kind of issues might occur regarding the informed consent process?

      The informed consent process is a lengthy one. It usually requires multiple meetings with patients. The physician may often introduce the trial, but an oncology nurse is often the one who is sitting down and going through that consent on a more detailed level. For example, we need to make sure patients understand the numbers of visits that may be involved, so they understand that commitment. What kind of lab work will they be agreeing to? Is there additional lab work? For example, many studies will collect additional biomarkers or even biopsies or tissue samples that they want to perhaps use in later research and that patient has to understand that during the consent process so that they can make a decision on whether or not they want to participate.

      The consent process also involves the risks and benefits of participating in that trial. Patients need to understand what the potential risks are, and what are the potential benefits. What happens if they don't go on this trial? That's all a part of that consent process to make sure that they understand what they are committing to.

      What important information would you like to give oncology nurses regarding clinical trials?

      I hope that oncology nurses learn that they are a valued piece of that puzzle in getting patients on trials. I hope they learn to know how to better explain what a clinical trial means to a patient, where they can get their answers if they have questions, and how to find a clinical trial. Any oncology nurse or a patient can go to clinicaltrials.gov and really search and help identify potential trials or a center that might be participating in multiple trials that could have something to offer.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman with brown hair and bangs
      Photo of a man wearing a suit in front of an Oncology Nursing News backdrop
      Related Content

      Image of a bladder surrounded by cancer cells.

      What Should Nurses Know: Gemcitabine Intravesical System’s Approval

      Bridget Hoyt
      September 16th 2025
      Article

      The Vitals

      What New Cancer Drugs Were Approved in 2023?

      Lindsay Fischer
      September 16th 2025
      Podcast

      Illustration of a lung under a magnifying glass

      Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC

      Kristi Rosa
      September 16th 2025
      Article

      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      September 16th 2025
      Podcast

      Diagram of endometrial cancer

      Rx Road Map: Durvalumab for Endometrial Cancer

      Abigail T. Ramontal, MHP, MSN, APRN-FP-C
      September 16th 2025
      Article

      Photo of a document that says "FDA" in a folder with medicine viles in front of it

      FDA Accepts Relacorilant NDA for Platinum-Resistant Ovarian Cancer

      Bridget Hoyt
      September 16th 2025
      Article
      Related Content

      Image of a bladder surrounded by cancer cells.

      What Should Nurses Know: Gemcitabine Intravesical System’s Approval

      Bridget Hoyt
      September 16th 2025
      Article

      The Vitals

      What New Cancer Drugs Were Approved in 2023?

      Lindsay Fischer
      September 16th 2025
      Podcast

      Illustration of a lung under a magnifying glass

      Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC

      Kristi Rosa
      September 16th 2025
      Article

      The Vitals

      Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

      Lindsay Fischer
      September 16th 2025
      Podcast

      Diagram of endometrial cancer

      Rx Road Map: Durvalumab for Endometrial Cancer

      Abigail T. Ramontal, MHP, MSN, APRN-FP-C
      September 16th 2025
      Article

      Photo of a document that says "FDA" in a folder with medicine viles in front of it

      FDA Accepts Relacorilant NDA for Platinum-Resistant Ovarian Cancer

      Bridget Hoyt
      September 16th 2025
      Article

      Latest Conference Coverage

      Nurses Lead Toxicity Monitoring in Indolent Lymphoma Care

      Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC

      Lutetium Lu 177 Dotatate Brings Partial Response in Metastatic BP-NETs

      Safety Management With Amivantamab Plus Lazertinib in NSCLC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      259 Prospect Plains Rd, Bldg H,
      Monroe, NJ 08831

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.